My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SIGA Technologies Inc. - Common Stock (NQ:SIGA)

8.900 +0.120 (+1.37%)
Streaming Delayed Price Updated: 9:48 AM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about SIGA Technologies Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Bottom Fishing: 3 Stocks Near Their 52-Week Lows Angling for a Bounce Back
While bottom fishing the market always presents risks, these stocks near 52-week lows offer enticing frameworks for speculation. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday's session saw 43 companies set new 52-week lows. 
Via Benzinga
Alibaba, Arcellx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
3 Cheap Stocks to Buy for Under $10 in June
While wagering on low-cost securities presents great risks, astute gamblers may want to check out these stocks under $10 to buy. 
Via InvestorPlace
Overview Of Value Stocks In The Healthcare Sector
 
Via Benzinga
SIGA Updates on Progress Its Smallpox Drug Trials For Potential Use Against Monkeypox
 
Via Benzinga
SIGA Technologies Bags New DoD Contract For Monkeypox Treatment
 
Via Benzinga
Tesla And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. AMC Entertainment Holdings, Inc. (NYSE: APE) shares dropped 8.4% to $1.75... 
Via Benzinga
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases... 
Via Benzinga
A New BioTech Research Race Is Focused On Improving Life For MS Patients
When the world is focused on a global pandemic no one saw coming four years ago, the attention given to escalating diseases with no known cure can be hidden from the public consciousness. This is... 
Via Benzinga
Dear Revlon (REV) Stock Fans, Prepare for Delisting
REV stock will be delisted soon. Revlon's shares will trade on an over-the-counter market, though they will likely eventually be worthless. 
Via InvestorPlace
SIGA Announces $16M Procurement Orders For Its Monkeypox Treatment
 
Via Benzinga
Researchers Behind COVID-19 RECOVERY Trial Launch New Monkeypox Treatment Trial
 
Via Benzinga
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion. 
Via Benzinga
RIDE Stock Alert: Lordstown Motors Just Hit Key EV Milestone
Lordstown Motors (RIDE) stock is sliding lower on Thursday even after announcing commercial production of its Endurance pickup truck. 
Via InvestorPlace
What Is Going on With Sobr Safe (SOBR) Stock Today?
Sobr Safe (SOBR) stock is falling on Friday after announcing the pricing of a $6 million private placement with institutional investors. 
Via InvestorPlace
SIGA Stock Alert: Siga Technologies Receives $11 Million Order for Monkeypox Drug
The price action in SIGA stock is counterintuitive today as the shares are down even while Siga Technologies locks down a lucrative contract. 
Via InvestorPlace
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
As cases of the monkeypox virus continue to grow, the race is on for a way to fight this once-rare disease.  Since the first reports of monkeypox infection in the United States started popping up in... 
Via Benzinga
FedEx, UPS And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded lower this morning after recording losses in the previous session. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
7 Top-Rated Biotech Stocks to Buy for Q4
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter. 
Via InvestorPlace
Meet Our Satanist Monkeypox Czar
Since our leaders are repeating their AIDS tack of not trying to rein in the irresponsible individuals spreading this disease, we’re left with America’s preferred response: pharmaceuticals. 
Via Talk Markets
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
 
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,700 Today
SIGA Technologies (NASDAQ:SIGA) has outperformed the market over the past 5 years by 26.33% on an annualized basis producing an average annual return of 36.11%. Currently, SIGA Technologies has a... 
Via Benzinga
3 Picks That Could Be the Next Meme Stock Champion
If you are looking for the next meme stock champion, here are three picks that are not AMC, Bed Bath & Beyond or GameStop. 
Via InvestorPlace
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed
 
Via Benzinga
Why Several Chinese Stocks Traded Higher; Here Are 58 Biggest Movers From Yesterday
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) surged 95.3% to close at $0.2580 on Thursday after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
  
Via Benzinga
SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report
In an effort to prevent bioterrorism attacks, just in case, SIGA Technologies Inc (NASDAQ: SIGA) started working on the smallpox treatment, Tpoxx, after the 9/11 terrorist attack that shook the world.... 
Via Benzinga
Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch
The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply. 
Via Benzinga
Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.